EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

When Illness Becomes Debt: Catastrophic Health Expenditures and Financial Distress—Evidence From India's Healthcare System

Neha Parikh, Krishna Chaitanya Vadlamannati

World Medical & Health Policy · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

ABSTRACT This study examines the association between catastrophic health expenditure (CHE) and distress financing among India's uninsured “missing middle,” a population largely excluded from public insurance schemes and private coverage. While healthcare‐induced financial hardship is well documented, evidence on subsequent coping strategies among this unprotected demographic remains limited. Using nationally representative data from the 75th round of the National Sample Survey Organisation (NSSO, 2017–18), we analyze 36,610 hospitalized individuals. CHE is defined as out‐of‐pocket spending exceeding 10% of annualized household consumption. Distress financing is measured as reliance on borrowing, asset sales, or informal contributions to fund hospitalization. Employing Linear Probability and Logit estimators controlling for state fixed effects, we find that experiencing CHE is associated with a 24‐percentage point increase in the probability of resorting to distress financing. Furthermore, our interaction models reveal that the marginal association between CHE and distress financing is smaller for private hospital users compared to public hospital users. This does not imply that private care offers greater financial protection. Instead, this difference likely reflects socioeconomic‐based selection and differential access to credit among patients opting for private facilities. These findings underscore the acute vulnerability of India's missing middle to health‐related economic shocks. This highlights an urgent policy need to expand equitable risk‐pooling, strengthen prepayment mechanisms, and design comprehensive financial protection strategies. The study contributes to the understanding of health‐induced financial distress and provides empirical insights relevant for the design of equitable and resilient healthcare financing policies in developing economies.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Neha Parikh, Krishna Chaitanya Vadlamannati
Quelle
World Medical & Health Policy
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
1948-4682, 1948-4682
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Neha Parikh, Krishna Chaitanya Vadlamannati (2026). When Illness Becomes Debt: Catastrophic Health Expenditures and Financial Distress—Evidence From India's Healthcare System. World Medical & Health Policy. https://doi.org/10.1002/wmh3.70090
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1 · Lizenz 2